The above chart presents the market trend analysis for leica biosystems from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 42 transactions, with a transaction quantity of 45.22 and a transaction weight of 772.1.
leica biosystems is International Buyer&Supplier,
and primarily engages in the import and export business of products such as laboratory reagent,assy,pc.
According to the 52wmb.com global trade database, as of 2024-11-08, the company has completed 807 international trades,
with its main trading regions covering philippines,ecuador,russia etc.
The core products include HS3822009000,HS90330000000,HS38221900000 etc,
often transported via heathrow apt london,port reino unido, port manchester gb etc,
and its main trading partners are mrl cybertec corp.,ecuainsutec tecnologia medica y cientifica s.a.,ооо биолайн.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on leica biosystems is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.